Instil Bio, Inc.TILNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-20.9%
5Y CAGR+16.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-20.9%/yr
Annual compound
5Y CAGR
+16.4%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$30.79M-30.3%
2024$44.21M-7.0%
2023$47.55M-23.6%
2022$62.23M+21.3%
2021$51.31M+256.7%
2020$14.38M+462.3%
2019$2.56M-